Immediate Impact
57 standout
Citing Papers
Efficacy and safety of the muscarinic receptor agonist KarXT (xanomeline–trospium) in schizophrenia (EMERGENT-2) in the USA: results from a randomised, double-blind, placebo-controlled, flexible-dose phase 3 trial
2023 Standout
Muscarinic Cholinergic Receptor Agonist and Peripheral Antagonist for Schizophrenia
2021 Standout
Works of S Mukherjee being referenced
Perception of tardive dyskinesia in outpatients receiving maintenance neuroleptics
1982
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| S Mukherjee | 125 | 7 | 8 | 82 | 48 | 18 | 305 | |
| Berko Milleit | 99 | 26 | 3 | 41 | 78 | 14 | 350 | |
| Sara Pompanin | 65 | 11 | 5 | 90 | 43 | 13 | 315 | |
| Ralph Shulman | 66 | 7 | 1 | 96 | 72 | 14 | 320 | |
| James B. Wirth | 141 | 10 | 7 | 64 | 9 | 347 | ||
| Kenya A. Costa-Dookhan | 180 | 24 | 12 | 98 | 14 | 349 | ||
| Mercedes Zumárraga | 151 | 23 | 32 | 27 | 33 | 333 | ||
| M. Said Berilgen | 173 | 14 | 2 | 23 | 114 | 18 | 316 | |
| Megan C. Bakeberg | 39 | 7 | 5 | 180 | 56 | 16 | 342 | |
| Karl‐Jürgen Bär | 55 | 3 | 1 | 13 | 64 | 12 | 349 | |
| R. Leadbetter | 194 | 9 | 18 | 82 | 10 | 287 |
All Works
Login with ORCID to disown or claim papers
Loading papers...